CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
CYP2C19 Polymorphism and proton pump inhibitors (PPI) in Helicobacter Pylori eradication therapy–A Metaanalysis
DOI 10.1055/s-2004-831520
Bibliografische Angaben
Nachweis in CareLit
Autor:innenGG Treiber, M Schwab, U Klotz
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: PPI are metabolised by the polymorphic CYP2C19. H.pylori eradication results according to different PPIs and dosages are inconsistent. Data from asian studies suggested that poor metabolisers of PPIs do better, data in caucasians are scarce. Objective/Methods: Meta-analysis of available literature data. Results: By mid of 2003, 12 studies met the inclusion criteria and reported differences in eradication outco…
Zitieren
Zitierempfehlung
GG Treiber, M Schwab, U Klotz (2004) CYP2C19 Polymorphism and proton pump inhibitors (PPI) in Helicobacter Pylori eradication therapy–A Metaanalysis. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-2004-831520
Mit CareLit weiterarbeiten